Simcere Pharmaceutical Group appoints Tamas Oravecz as SVP,CSO

Simcere Pharmaceutical Group announces recently the appointment of Tamas Oravecz, Ph.D. as Senior Vice President(SVP), Chief Scientific Officer(CSO) of the Simcere U.S. Tamas will be responsible for providing strategic leadership to our drug discovery efforts in America, building and overseeing preclinical drug development programs from concept and target validation through IND submission. “Welcome Dr. Tamas Oravecz to join […]